Product NDC: | 0781-3177 |
Proprietary Name: | Ceftazidime |
Non Proprietary Name: | Ceftazidime |
Active Ingredient(s): | 1 g/1 & nbsp; Ceftazidime |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0781-3177 |
Labeler Name: | Sandoz Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA062640 |
Marketing Category: | ANDA |
Start Marketing Date: | 20080515 |
Package NDC: | 0781-3177-96 |
Package Description: | 25 VIAL, SINGLE-DOSE in 1 TRAY (0781-3177-96) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (0781-3177-80) |
NDC Code | 0781-3177-96 |
Proprietary Name | Ceftazidime |
Package Description | 25 VIAL, SINGLE-DOSE in 1 TRAY (0781-3177-96) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (0781-3177-80) |
Product NDC | 0781-3177 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Ceftazidime |
Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20080515 |
Marketing Category Name | ANDA |
Labeler Name | Sandoz Inc |
Substance Name | CEFTAZIDIME |
Strength Number | 1 |
Strength Unit | g/1 |
Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |